Arcutis Biotherapeutics I... (ARQT)

ARQT trades at $19.92, 13.8% above the near-term max pain of $17.5 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($10-$97.5), signaling increased put positioning or downside protection. Key magnetic zone at 15 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ARQT shows a downward trend from 97.5 to 10, indicating bearish sentiment or hedging activity. The 331% spread signals divergent expectations across timeframes. Most levels below 19.92 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.